These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Combinations of avibactam and carbapenems exhibit enhanced potencies against drug-resistant Mycobacterium abscessus. Kaushik A; Gupta C; Fisher S; Story-Roller E; Galanis C; Parrish N; Lamichhane G Future Microbiol; 2017 May; 12(6):473-480. PubMed ID: 28326811 [TBL] [Abstract][Full Text] [Related]
5. Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane β-Lactamase Inhibitor To Augment β-Lactam Action. Dousa KM; Nguyen DC; Kurz SG; Taracila MA; Bethel CR; Schinabeck W; Kreiswirth BN; Brown ST; Boom WH; Hotchkiss RS; Remy KE; Jacono FJ; Daley CL; Holland SM; Miller AA; Bonomo RA mBio; 2022 Feb; 13(1):e0352921. PubMed ID: 35073757 [TBL] [Abstract][Full Text] [Related]
6. Synergistic effects of sulopenem in combination with cefuroxime or durlobactam against Dousa KM; Shin E; Kurz SG; Plummer M; Nantongo M; Bethel CR; Taracila MA; Nguyen DC; Kreiswith BN; Daley CL; Remy KE; Holland SM; Bonomo RA mBio; 2024 Jun; 15(6):e0060924. PubMed ID: 38742824 [TBL] [Abstract][Full Text] [Related]
7. Dual β-lactam therapy to improve treatment outcome in Mycobacterium abscessus disease. Pozuelo Torres M; van Ingen J Clin Microbiol Infect; 2024 Jun; 30(6):738-742. PubMed ID: 38527611 [TBL] [Abstract][Full Text] [Related]
8. The Fröberg G; Ahmed A; Chryssanthou E; Davies Forsman L Antimicrob Agents Chemother; 2023 Oct; 67(10):e0052823. PubMed ID: 37671880 [TBL] [Abstract][Full Text] [Related]
9. Impact of acquired broad-spectrum β-lactamases on susceptibility to oral penems/carbapenems (tebipenem, sulopenem, and faropenem) alone or in combination with avibactam and taniborbactam β-lactamase inhibitors in Le Terrier C; Nordmann P; Bouvier M; Poirel L Antimicrob Agents Chemother; 2023 Oct; 67(10):e0054723. PubMed ID: 37668385 [TBL] [Abstract][Full Text] [Related]
10. Activity of Oral Tebipenem-Avibactam in a Mouse Model of Mycobacterium abscessus Lung Infection. Negatu DA; González Del Río R; Cacho-Izquierdo M; Barros-Aguirre D; Lelievre J; Rullas J; Casado P; Ganapathy US; Zimmerman MD; Gengenbacher M; Dartois V; Dick T Antimicrob Agents Chemother; 2023 Feb; 67(2):e0145922. PubMed ID: 36688684 [TBL] [Abstract][Full Text] [Related]
11. New β-Lactamase Inhibitors Nacubactam and Zidebactam Improve the Kaushik A; Ammerman NC; Parrish NM; Nuermberger EL Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209013 [TBL] [Abstract][Full Text] [Related]
12. β-Lactamase inhibition by avibactam in Mycobacterium abscessus. Dubée V; Bernut A; Cortes M; Lesne T; Dorchene D; Lefebvre AL; Hugonnet JE; Gutmann L; Mainardi JL; Herrmann JL; Gaillard JL; Kremer L; Arthur M J Antimicrob Chemother; 2015 Apr; 70(4):1051-8. PubMed ID: 25525201 [TBL] [Abstract][Full Text] [Related]
16. The addition of avibactam renders piperacillin an effective treatment for Meir M; Bifani P; Barkan D Antimicrob Resist Infect Control; 2018; 7():151. PubMed ID: 30564307 [TBL] [Abstract][Full Text] [Related]
17. In vitro effects of diazabicyclooctane β-lactamase inhibitors relebactam and nacubactam against three subspecies of Mycobacterium abscessus complex. Misawa K; Nishimura T; Kashimura S; Enoki Y; Taguchi K; Uno S; Uwamino Y; Matsumoto K; Hasegawa N Int J Antimicrob Agents; 2022; 60(5-6):106669. PubMed ID: 36064079 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of the β-Lactamase Bla Lefebvre AL; Le Moigne V; Bernut A; Veckerlé C; Compain F; Herrmann JL; Kremer L; Arthur M; Mainardi JL Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096155 [No Abstract] [Full Text] [Related]
19. Impact of relebactam-mediated inhibition of Mycobacterium abscessus BlaMab β-lactamase on the in vitro and intracellular efficacy of imipenem. Le Run E; Atze H; Arthur M; Mainardi JL J Antimicrob Chemother; 2020 Feb; 75(2):379-383. PubMed ID: 31637424 [TBL] [Abstract][Full Text] [Related]
20. First Penicillin-Binding Protein Occupancy Patterns for 15 β-Lactams and β-Lactamase Inhibitors in Mycobacterium abscessus. Sayed ARM; Shah NR; Basso KB; Kamat M; Jiao Y; Moya B; Sutaria DS; Lang Y; Tao X; Liu W; Shin E; Zhou J; Werkman C; Louie A; Drusano GL; Bulitta JB Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33106266 [No Abstract] [Full Text] [Related] [Next] [New Search]